Matthew Doctor has been the CEO of Regis Corporation since May 2022, having started as the interim CEO in December 2021. He has a solid background in the restaurant industry, previously serving as the Chief Strategy Officer at Regis and...

Matthew Doctor has been the CEO of Regis Corporation since May 2022, having started as the interim CEO in December 2021. He has a solid background in the restaurant industry, previously serving as the Chief Strategy Officer at Regis and as a partner at Kava Restaurants, a Tim Horton's franchisee. Before that, he worked with Restaurant Brands International, where he held important roles like Head of Global Development for Burger King. He began his career in investment banking with J.P. Morgan. Matthew's leadership at Regis comes with a focus on transforming the company into a fully franchised model, aiming to provide better support to franchisees. His compensation for 2022 included a base salary of $600,000 and significant stock options, valuing at market rates, to align his interests with shareholders. This reflects a trend of executive pay being tied to performance and company success. Matthew's approach combines his experience from different sectors to steer Regis towards financial growth and stronger franchise operations.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Regis Corporation CEOs

R

Matthew Doctor

CEO of Regis Corporation

Education

Not specified

Field of Expertise

Business & Management

Sector of Economy

Consumer Cyclical

Born

January 1, 1987 - 38 years ago

CEO of Regis Corporation for

3 years 0 months (May 2022 - Present)

Previous Experience

Executive Vice President and Chief Strategy Officer, Chief Financial Officer of Kava Restaurants LLC, various roles at Restaurant Brands International

Rivals

Competitors/colleagues of Matthew Doctor

Holdings

See how much did Matthew Doctor make over time.

Matthew Doctor has actively managed his stock holdings in Regis Corporation, with significant trading activity reflecting his confidence in the company. In 2021, he performed a series of trades starting from February, with peaks of around $369K in April. As...

Matthew Doctor has actively managed his stock holdings in Regis Corporation, with significant trading activity reflecting his confidence in the company. In 2021, he performed a series of trades starting from February, with peaks of around $369K in April. As he transitioned to CEO, his trades appear more cautious, indicating a strategic approach to managing his wealth tied to the company’s performance. His options agreement grants him the potential to purchase 875,000 shares, setting the exercise price at the closing value on his start date, which highlights his commitment to the company's long-term growth. By aligning his financial interests with the shareholders, Matthew maintains a proactive engagement with the company’s future performance, emphasizing the importance of stock value appreciation in his strategy.

Mar 17, 2025

R

shares

RGS @ $18.25

Insider Trading

See recent insider trades of Matthew Doctor.

RGS

$64.85K

RGS at $1.38/share

Nov 5, 2021

Received

RGS

46,344 shares

RGS

Nov 5, 2021

Received

RGS

28,382 shares

RGS

Feb 8, 2021

Received

Compensation History

See how much did Matthew Doctor make over time.

In 2022, Matthew Doctor's total compensation was approximately $1.94 million, which includes a base salary of $600,000 and a performance-related bonus of about $259,000. This bonus was tied to the company’s strong performance against its Adjusted EBITDA metric. He was also awarded stock options for 875,000 shares, which are set to vest over three years, divided into increments of 20%, 20%, and 60%. This long-term incentive plan indicates a strategy to motivate him to drive Regis Corporation’s financial success. The design of his pay structure aligns his personal financial growth with the company’s overall performance, reinforcing a common practice in executive compensation. It’s important to note that he did not vest in any stock awards during 2022 due to prior large equity grants, suggesting that the board had made significant previous commitments to his compensation.

Year

2022

Total Compensation

$897.86K

Salary

$600.00K

Board Justification

The executive compensation programs are designed to reward executives for achieving financial and business goals while aligning their interests with those of shareholders.

Bonus

$259.00K

Board Justification

Discretionary bonus payments made for One-Time Cash Bonuses and ReFi Recognition Bonuses due to the Company’s over performance on the Adjusted EBITDA metric.

Other

$38.86K

Board Justification

Includes company match and profit-sharing contributions to retirement savings plans.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards vested in 2022 as Mr. Doctor did not receive an annual long-term equity grant in fiscal 2023 due to prior large equity awards.

Performance Metrics

Company performance metrics tied to target Adjusted EBITDA and key initiatives related to the Company’s ongoing performance.

Other Regis Corporation CEOs

Here are other CEOs of Regis Corporation

Felipe A. Athayde

Ex-CEO of Regis Corporation

March 2019 - March 2022